The pharmaceutical sector faces persistent supply chain challenges as estrogen patch manufacturers cannot meet surging demand across the United States. Recent shifts in federal healthcare policies have dramatically increased patient prescriptions, overwhelming production capacities. Industry leaders warn that distribution bottlenecks and manufacturing constraints continue to exacerbate shortages, affecting millions of women seeking hormone replacement therapy and related treatments. Supply stabilization efforts remain ongoing.

Summary auto-generated by AI from the original publisher's content. Editorial standards.